Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TRIB
#5070
Trinity Biotech plc
0.7
2
0.00%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
0.00%
Variazione Mensile
-22.58%
Variazione di 6 mesi
-52.63%
Variazione Annuale
-5.26%
Chiusura Precedente
0.7
2
Open
0.7
2
Bid
Ask
Low
0.7
2
High
0.7
2
Volume
1
Mercati
Mercato Azionario Statunitense
Salute
TRIB
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
16.72 M
16.72 M
30.49 M
153.31 M
359.19 M
559.71 M
Valuation ratios
Enterprise value
—
—
—
—
1.58 B
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.01
0.45
0.62
0.3
—
Return on equity %
2.71
2.91
18.84
1.54
0.89
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
47.64
40.96
29.48
34.22
34.83
—
Operating margin %
0.08
7.13
22.4
47.59
34.38
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
5.9
1
54.83
64.87
50.71
—
Liquidity ratios
Quick ratio
1.96
0.43
1.39
1.27
0.68
—
Current ratio
3.08
0.72
2.69
2.6
1.28
—
Inventory turnover
1.72
1.85
2.04
1.76
2.04
—
Asset turnover
0.78
0.75
0.71
0.75
0.76
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Notizie
Trinity Biotech obtiene financiamiento de capital por $25 millones
Trinity Biotech secures $25M equity financing facility
Trinity Biotech recibe aviso de exclusión de Nasdaq por incumplimiento
Trinity Biotech recibe aviso de exclusión del Nasdaq
Trinity Biotech recibe aviso de exclusión del Nasdaq
Trinity Biotech receives Nasdaq delisting warning notice
Trinity Biotech recibe aprobación final para cambio en fabricación de prueba VIH
Trinity Biotech recibe aprobación final para cambio en fabricación de prueba de VIH
Trinity Biotech receives final approval for HIV test manufacturing shift
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification
Las acciones de Trinity Biotech se disparan tras un importante pedido de pruebas de VIH
Acciones de Trinity Biotech se disparan tras gran pedido de pruebas de VIH